Archives

4th Boston Biotechnology Virtual Summit

www.bostonbiotechnologysummit.com The 4th Boston ● Paris Biotechnology Virtual Summit ● Focus on Covid-19 – will be held, via a zoom platform, on Thursday 15 October 2020, 11 AM – 01 PM US EDT [17:00 – 19:00 EU CET] in three sequential panels as below. The Program Committee, listed below*, have convened renowned experts...

Continue reading »

Stroke is the Second Cause of Mortality Worldwide: ACTICOR-BIOTECH Expands ACTIMIS Stroke Study to the UNITED STATES — Shahin Gharakhanian MD Consulting LLC Leads Nationwide Project from Cambridge MA

Cambridge MA, 02.03.2020. Stroke is listed as the 2nd cause of mortality worldwide according to the World Health Organization. ACTICOR-BIOTECH [CEO: Dr Gilles AVENARD], a leading, fully-funded, PARIS-based, biotechnology company is assessing its novel agent ACT017 as an add on therapy to Standard of Care in AIS: Acute Ischemic Stroke. This year Acticor-Biotech...

Continue reading »

Shahin Gharkhanian MD is Founder-Lead Organizer of the < 1st Boston Paris Biotechnology Summit™ > to be held at the Institut Pasteur, Paris, France, 18 May 2017.

Event’s Mission “the 1st Boston – Paris Biotechnology Summit is a novel catalyst event aiming to provide facilitative leadership for talents in both cities in order to foster energies and synergies, to spark new projects and to generate funding opportunities”. Website: bostonbiotechnologysummit.com Information: blendofconcept@gmail.com

Continue reading »